Studies in neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease
and Amyotrophic lateral sclerosis, Huntington's disease, and so on, have suggested that …

Parkinson's disease (PD) is a progressive neurodegenerative disorder that primarily affects
elderly people and constitutes a major source of disability worldwide. Notably, the …

Parkinson's disease (PD) is the second most common neurodegenerative disease amongst
the middle‑aged and elderly populations. Several studies have confirmed that the microbiota …

Neurodegenerative diseases are characterized by progressive loss of selectively vulnerable
neuronal populations, which contrasts with selectively static loss of neurons due to toxic or …

Many neurodegenerative diseases are characterized by progressive loss of neurons and
abnormal protein accumulation, including amyloid (A) β and tau in Alzheimer's disease and …

Parkinson disease (PD) used to be considered a nongenetic condition. However, the
identification of several autosomal dominant and recessive mutations linked to monogenic …

Symptomatic treatment options for Parkinson disease have steadily improved, and
individualized therapeutic approaches are becoming established for every stage of the …

Parkinson's disease is a neurodegenerative disorder mainly characterized by the
degeneration of dopaminergic neurons in the substantia nigra. Degenerating neurons …

Parkinson's Disease (PD) is characterized both by the loss of dopaminergic neurons in the
substantia nigra and the presence of cytoplasmic inclusions called Lewy Bodies. These …

Vaccination is increasingly being investigated as a potential treatment for synucleinopathies,
a group of neurodegenerative diseases including Parkinson's disease, multiple system …